Clarissa Cola Salvatore Brugaletta Victoria Martín Yuste Bieito Campos Dominick J Angiolillo Manel Sabaté
10.2147/vhrm.s4248
Vasc Health Risk Manag
2009;5(1):101-19.
antiplatelet therapy diabetes mellitus drug-eluting stent platelet function stent thrombosis
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/19436654/
Angioplasty, Balloon, Coronary / adverse effects Coronary Stenosis / therapy Coronary Thrombosis / etiology Diabetes Mellitus, Type 2 / complications Myocardial Infarction / therapy
Angioplasty, Balloon, Coronary / adverse effects Coronary Stenosis / therapy Coronary Thrombosis / etiology Diabetes Mellitus, Type 2 / complications Myocardial Infarction / therapy Case Reports Review Angioplasty, Balloon, Coronary / instrumentation Aspirin / therapeutic use Cardiovascular Agents / administration & dosage Clopidogrel Coronary Angiography Coronary Stenosis / diagnostic imaging Coronary Stenosis / etiology Coronary Thrombosis / diagnostic imaging Coronary Thrombosis / therapy Drug-Eluting Stents Female Humans Medication Adherence Middle Aged Myocardial Infarction / diagnostic imaging Myocardial Infarction / etiology Platelet Aggregation Inhibitors / therapeutic use Risk Factors Sirolimus / administration & dosage Ticlopidine / analogs & derivatives Ticlopidine / therapeutic use Treatment Outcome Cardiovascular Agents Platelet Aggregation Inhibitors Clopidogrel Ticlopidine Aspirin Sirolimus
PMC2672443
19436654
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization
2009